Glaukos (GKOS) News Today $144.00 +3.17 (+2.25%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Connor Clark & Lunn Investment Management Ltd. Has $6.11 Million Position in Glaukos Co. (NYSE:GKOS)Connor Clark & Lunn Investment Management Ltd. lessened its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 47.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 46,913 shares of the medical instruments supplier's stock after selling 42,798 sharNovember 23 at 4:33 AM | marketbeat.com10,339 Shares in Glaukos Co. (NYSE:GKOS) Bought by B. Metzler seel. Sohn & Co. Holding AGB. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Glaukos Co. (NYSE:GKOS - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 10,339 shares of the medical instruments supplier's stock, valueNovember 23 at 4:11 AM | marketbeat.comGlaukos (NYSE:GKOS) Sets New 1-Year High - Time to Buy?Glaukos (NYSE:GKOS) Sets New 1-Year High - Should You Buy?November 22 at 1:32 PM | marketbeat.comPrimecap Management Co. CA Increases Stock Position in Glaukos Co. (NYSE:GKOS)Primecap Management Co. CA raised its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 2.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,245,185 shares of the medical instruments supplier's stock after buNovember 22 at 5:53 AM | marketbeat.comStifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS)November 21 at 5:31 PM | markets.businessinsider.comGlaukos Co. (NYSE:GKOS) is Brown Capital Management LLC's 4th Largest PositionBrown Capital Management LLC cut its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 13.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,634,591 shares of the medical instruments supplier's stock after seNovember 21 at 8:49 AM | marketbeat.comGlaukos Co. (NYSE:GKOS) Shares Sold by Segall Bryant & Hamill LLCSegall Bryant & Hamill LLC decreased its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 3.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 105,956 shares of the medical instruments supplier's stock after selling 4,327 shares during theNovember 21 at 5:14 AM | marketbeat.comGlaukos Co. (NYSE:GKOS) Shares Bought by Victory Capital Management Inc.Victory Capital Management Inc. boosted its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 421.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 79,211 shares of the medical instruments supNovember 21 at 3:17 AM | marketbeat.comFirst Turn Management LLC Purchases Shares of 96,097 Glaukos Co. (NYSE:GKOS)First Turn Management LLC purchased a new stake in Glaukos Co. (NYSE:GKOS - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 96,097 shares of the medical instruments supplier's stock, valued at apprNovember 19, 2024 | marketbeat.comLMR Partners LLP Purchases 4,059 Shares of Glaukos Co. (NYSE:GKOS)LMR Partners LLP boosted its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 12.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 36,986 shares of the medical instruments supplier's stock after buying an addiNovember 19, 2024 | marketbeat.comGlaukos Corporation (NYSE:GKOS) Presents Investor Presentation; Prepares for Launch of iDose TR TherapyNovember 18, 2024 | americanbankingnews.comOppenheimer Asset Management Inc. Sells 3,974 Shares of Glaukos Co. (NYSE:GKOS)Oppenheimer Asset Management Inc. decreased its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 21.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,680 shares of the medical instruments supplier's stockNovember 17, 2024 | marketbeat.comGlaukos Revolutionizes Glaucoma Treatment with iDose TR ApprovalNovember 16, 2024 | markets.businessinsider.comGlaukos Co. (NYSE:GKOS) Shares Bought by WCM Investment Management LLCWCM Investment Management LLC raised its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 45.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 99,155 shares of the medical instruments supplier's stock after acNovember 12, 2024 | marketbeat.comPrincipal Financial Group Inc. Decreases Stock Holdings in Glaukos Co. (NYSE:GKOS)Principal Financial Group Inc. cut its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 3.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 288,505 shares of the medical instruments supplier's stock after selling 9,44November 12, 2024 | marketbeat.comGlaukos Co. (NYSE:GKOS) Shares Sold by Lisanti Capital Growth LLCLisanti Capital Growth LLC trimmed its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 48.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,330 shares of the medical instruNovember 11, 2024 | marketbeat.comWilliam Blair Issues Positive Forecast for Glaukos EarningsGlaukos Co. (NYSE:GKOS - Free Report) - Stock analysts at William Blair increased their Q4 2024 earnings per share estimates for Glaukos in a research report issued on Tuesday, November 5th. William Blair analyst M. Andrew now anticipates that the medical instruments supplier will post earnings pNovember 8, 2024 | marketbeat.comGlaukos Corporation (NYSE:GKOS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?November 7, 2024 | finance.yahoo.comGlaukos (GKOS) Receives a Buy from Truist FinancialNovember 6, 2024 | markets.businessinsider.comGlaukos (GKOS) Receives a Buy from Piper SandlerNovember 6, 2024 | markets.businessinsider.comUncertain Growth and Reimbursement Challenges Keep Glaukos’s iDose at Hold RatingNovember 6, 2024 | markets.businessinsider.comGlaukos price target raised to $145 from $135 at Wells FargoNovember 6, 2024 | finance.yahoo.comGlaukos Corporation (NYSE:GKOS) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | msn.comGlaukos (NYSE:GKOS) Shares Gap Down - Here's What HappenedGlaukos (NYSE:GKOS) Shares Gap Down - Here's What HappenedNovember 5, 2024 | marketbeat.comGlaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain HeadwindsNovember 5, 2024 | benzinga.comGlaukos (NYSE:GKOS) Posts Earnings Results, Beats Expectations By $0.20 EPSGlaukos (NYSE:GKOS - Get Free Report) issued its quarterly earnings results on Monday. The medical instruments supplier reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.20. Glaukos had a negative net margin of 47.39% and a negative return on equity of 22.51%. The business had revenue of $96.70 million for the quarter, compared to analysts' expectations of $91.50 million. During the same quarter last year, the company posted ($0.50) earnings per share. The company's quarterly revenue was up 23.9% compared to the same quarter last year.November 5, 2024 | marketbeat.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) StockJPMorgan Chase & Co. upped their price objective on shares of Glaukos from $130.00 to $145.00 and gave the stock an "overweight" rating in a research report on Tuesday.November 5, 2024 | marketbeat.comGlaukos Reports Record Sales Despite Net LossNovember 5, 2024 | markets.businessinsider.comGlaukos Corp. Reports Record Third-Quarter Sales GrowthNovember 5, 2024 | markets.businessinsider.comGlaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sales and Raised Guidance Amid ...November 5, 2024 | finance.yahoo.comGlaukos Co. (NYSE:GKOS) Given Average Rating of "Moderate Buy" by BrokeragesShares of Glaukos Co. (NYSE:GKOS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and eight have issued aNovember 5, 2024 | marketbeat.comGlaukos Corporation (GKOS) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | seekingalpha.comGlaukos Co. (NYSE:GKOS) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund cut its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 21.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 393,110 shares of the medical instruments supplierNovember 3, 2024 | marketbeat.comEarnings To Watch: Glaukos Corp (GKOS) Reports Q3 2024 ResultNovember 2, 2024 | finance.yahoo.comInsider Selling: Glaukos Co. (NYSE:GKOS) COO Sells 2,275 Shares of StockNovember 2, 2024 | insidertrades.comHow Is The Market Feeling About Glaukos?November 1, 2024 | benzinga.comCreative Planning Acquires 4,937 Shares of Glaukos Co. (NYSE:GKOS)Creative Planning boosted its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 64.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,643 shares of the medical instruments supplier's stock after buying an aOctober 30, 2024 | marketbeat.comPositive U.S. Ophthalmologist Survey and Future Demand Boost Glaukos’s iDose and iStent Infinite Outlook, Reinforcing Buy RatingOctober 29, 2024 | markets.businessinsider.comGlaukos (NYSE:GKOS) Sets New 1-Year High - What's Next?Glaukos (NYSE:GKOS) Reaches New 1-Year High - Should You Buy?October 29, 2024 | marketbeat.comGlaukos (GKOS) Set to Post Earnings on MondayGlaukos (NYSE:GKOS) will be releasing earnings after the market closes on Monday, November 4, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634073)October 28, 2024 | marketbeat.comAssenagon Asset Management S.A. Increases Position in Glaukos Co. (NYSE:GKOS)Assenagon Asset Management S.A. grew its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 31.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 75,798 shares of the medical instruments supplier's stock after purchasing an additional 18,067 sharOctober 28, 2024 | marketbeat.comTaylor Frigon Capital Management LLC Sells 11,654 Shares of Glaukos Co. (NYSE:GKOS)Taylor Frigon Capital Management LLC trimmed its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 29.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,022 shares of the medical instrumentOctober 24, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Sells 21,757 Shares of Glaukos Co. (NYSE:GKOS)Allspring Global Investments Holdings LLC lessened its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 5.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 390,619 shares of the medical instruments supplier'sOctober 23, 2024 | marketbeat.comGlaukos (NYSE:GKOS) Upgraded by StockNews.com to "Hold"StockNews.com upgraded shares of Glaukos from a "sell" rating to a "hold" rating in a research report on Monday.October 21, 2024 | marketbeat.comGlaukos iDose: Transforming Glaucoma Treatment with Promising Growth PotentialOctober 21, 2024 | markets.businessinsider.comPromising Growth Outlook for Glaukos’s iDose Amid Positive Market Reception and Solid Reimbursement ProcessesOctober 21, 2024 | markets.businessinsider.comExchange Traded Concepts LLC Buys Shares of 5,793 Glaukos Co. (NYSE:GKOS)Exchange Traded Concepts LLC acquired a new position in shares of Glaukos Co. (NYSE:GKOS - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,793 shares of the medical instruments supplieOctober 19, 2024 | marketbeat.comGlaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual MeetingOctober 14, 2024 | finance.yahoo.comPrivate Advisory Group LLC Acquires New Shares in Glaukos Co. (NYSE:GKOS)Private Advisory Group LLC bought a new position in shares of Glaukos Co. (NYSE:GKOS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 6,738 shares of the medical instrumentOctober 12, 2024 | marketbeat.comGlaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4October 9, 2024 | stockhouse.com Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address I hate to say I told you so (Ad)Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock… Follow this link right away. GKOS Media Mentions By Week GKOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GKOS News Sentiment▼1.100.49▲Average Medical News Sentiment GKOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GKOS Articles This Week▼136▲GKOS Articles Average Week Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZBH News SOLV News SNN News PEN News BLCO News INSP News PRCT News NVST News AXNX News NARI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GKOS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glaukos Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Glaukos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
